𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: A case series and cohort study

✍ Scribed by L. A. Korswagen; G. M. Bartelds; C. L. M. Krieckaert; F. Turkstra; M. T. Nurmohamed; D. van Schaardenburg; C. A. Wijbrandts; P. P. Tak; W. F. Lems; B. A. C. Dijkmans; R. M. van Vugt; G. J. Wolbink

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
94 KB
Volume
63
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Are venous thromboembolic events associa
Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? : A case–control study of Medicare beneficiaries
✍ Blase N. Polite; Elizabeth B. Lamont 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND Multiple epidemiologic studies have reported associations between venous thromboembolic events and subsequent cancer diagnoses, but the published results have not suggested clear cancer screening approaches. ## METHODS Using data from the National Cancer Institute's Sur

A prospective cohort study determining t
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase : Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study
✍ Lesley G. Mitchell;; the PARKAA Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

## Abstract ## BACKGROUND Thrombotic events (TEs) are serious secondary complications in children with acute lymphoblastic leukemia (ALL) who receive L‐asparaginase (ASP) therapy; however, the prevalence of TEs has not been established. The primary objective of the Prophylactic Antithrombin Replac